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SCIENTIFIC OPINION  
Flavouring Group Evaluation 46, Revision 1 (FGE.46Rev1): 
Ammonia and three ammonium salts from chemical group 301 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
(CEF)2, 3  
European Food Safety Authority (EFSA), Parma, Italy 
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SUMMARY  
The Scientific Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (the 
Panel) was asked to provide scientific advice to the Commission on the implications for human health 
of chemically defined flavouring substances used in or on foodstuffs in the Member States. In 
particular, the Panel was requested to evaluate four flavouring substances in the Flavouring Group 
Evaluation 46, Revision 1 (FGE.46Rev1), using the Procedure as referred to in the Commission 
Regulation (EC) No 1565/2000. These four flavouring substances belong to chemical group 30, Annex 
I of the Commission Regulation (EC) No 1565/2000. 
The present Flavouring Group Evaluation deals with ammonia [FL-no: 16.009], and three ammonia 
salts (diammonium sulphide [FL-no: 16.002], ammonium chloride [FL-no: 16.048] and ammonium 
hydrogen sulphide [FL-no: 16.059]). 
The flavouring substances cannot exist as geometrical or optical isomers. 
                                                     
 
1  On request from the Commission, Question No EFSA-Q-2010-01133 adopted on 25 November 2010. 
2  Panel members Arturo Anadon, Mona-Lise Binderup, Wilfried Bursch, Laurence Castle, Riccardo Crebelli, Karl-Heinz 
Engel, Roland Franz, Nathalie Gontard, Thomas Haertle, Trine Husøy, Klaus-Dieter Jany, Catherine Leclercq, Jean 
Claude Lhuguenot, Wim Mennes, Maria Rosaria Milana, Karla Pfaff, Kettil Svensson, Fidel Toldra, Rosemary Waring, 
Detlef Wölfle. CEF-Unit@efsa.europa.eu  
3  Acknowledgement: The Panel wishes to thank the members of the Working Groups on Flavourings for the preparation of 
this Opinion: Ulla Beckman Sundh, Vibe Beltoft, Wilfried Bursch, Angelo Carere, Karl-Heinz Engel, Henrik Frandsen, 
Rainer Gürtler, Frances Hill, Trine Husøy, John Christian Larsen, Pia Lund, Wim Mennes, Gerard Mulder, Karin Nørby, 
Gerard Pascal, Iona Pratt, Gerrit Speijers, Harriet Wallin and EFSA’s staff member Kim Rygaard Nielsen for the support 
provided to this EFSA scientific output. 
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Two of the flavouring substances are classified into structural class I and two are classified into 
structural class III according to the decision tree approach presented by Cramer et al. (1978). 
The flavouring substance ammonia in the present group has been reported to occur naturally in a wide 
range of food items up to very high amounts. Hydrogen sulphide is also reported to occur naturally in 
a wide range of food items. 
In its evaluation, the Panel as a default used the “Maximised Survey-derived Daily Intake” (MSDI) 
approach to estimate the per capita intakes of the flavouring substances in Europe. However, when the 
Panel examined the information provided by the European Flavouring Industry on the use levels in 
various foods, it appeared obvious that the MSDI approach in a number of cases would grossly 
underestimate the intake by regular consumers of products flavoured at the use level reported by the 
Industry, especially in those cases where the annual production values were reported to be small. In 
consequence, the Panel had reservations about the data on use and use levels provided and the intake 
estimates obtained by the MSDI approach.  
In the absence of more precise information that would enable the Panel to make a more realistic 
estimate of the intakes of the flavouring substances, the Panel has decided also to perform an estimate 
of the daily intakes per person using a “modified Theoretical Added Maximum Daily Intake” 
(mTAMDI) approach based on the normal use levels reported by Industry. In those cases where the 
mTAMDI approach indicated that the intake of a flavouring substance might exceed its corresponding 
threshold of concern, the Panel decided not to carry out a formal safety assessment using the 
Procedure. In these cases the Panel requires more precise data on use and use levels. 
According to the default MSDI approach, the two flavouring substances [FL-no: 16.009 and 16.048] 
belonging to structural class I have estimated intakes in Europe of 34 and 140 microgram/capita/day, 
respectively, which are below the threshold of concern for structural class I substances (1800 
microgram/person/day). The two substances belonging to structural class III have estimated intake in 
Europe of 62 and 5.6 microgram/capita/day, respectively, which is below the threshold of concern for 
structural class III substances (90 microgram/person/day). 
Although the genotoxicity data for the flavouring substances in this group are limited, the available 
data on genotoxicity do not preclude an evaluation of the candidate substances through the Procedure. 
For the candidate substance ammonium chloride [FL-no: 16.048] there is a well-performed 
carcinogenicity study available, which indicates that the substance does not induce tumours. 
Ammonia is a substance that is readily absorbed in the gut. It is produced endogenously in amounts 
that far exceed those that are to be ingested as flavourings. The three ammonium salts are expected to 
give rise to ammonium ion and chloride or hydrogen sulphide. Ammonia is expected to be transported 
by the portal circulation to the liver and metabolised to urea by the Krebs urea cycle and subsequently 
excreted by the kidneys. Hydrogen sulphide is a substance that is produced endogenously. The major 
pathway for sulphide metabolism is oxidation to sulphate and excretion by the kidney. The major 
oxidation product of sulphide is thiosulphate which is then converted to sulphate. The primary location 
for these reactions is the liver. All four substances are accordingly expected to be metabolised to 
innocuous substances at the anticipated levels of intake as flavouring substances.  
It was noted that where toxicity data were available they were consistent with the conclusions in the 
present flavouring group evaluation using the Procedure. 
On the basis of the default MSDI approach the Panel concluded that the flavouring substances would 
not give rise to safety concerns at the estimated levels of intake arising from their use as flavouring 
substances. 
When the estimated intakes were based on the mTAMDI approach the values for the two substances 
from structural class I, ammonia and ammonium chloride [FL-no: 16.009 and 16.048], are 110000 
microgram/person/day and 220000 microgram/person/day, respectively. These values are above the 
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threshold of concern for structural class I of 1800 microgram/person/day. For one of the substances 
from structural class III, ammonium hydrogen sulphide [FL-no: 16.059], the mTAMDI value is 220 
microgram/person/day. This value is above the threshold for structural class III of 90 
microgram/person/day. For the other substance from structural class III no data are available on use 
and use levels.  
Thus, intake estimates based on the mTAMDI approach exceed the threshold of concern for the three 
flavouring substances in this flavouring group, and more reliable exposure data are requested for all 
four substances. On the basis of such additional data, these flavouring substances should be 
reconsidered using the Procedure. Subsequently, additional data might become necessary. 
In order to determine whether this evaluation could be applied to the materials of commerce, it is 
necessary to consider the available specifications. Specifications including complete purity criteria for 
the materials of commerce have been provided for the four flavouring substances.  
Identity tests is missing for one of the flavouring substances, ammoniun hydrogen sulphide [FL-no: 
16.059]. Thus, the final evaluation of the materials of commerce cannot be performed for this 
substance, pending further information. The remaining three flavouring substances, ammonia [FL-no: 
16.009], ammonium chloride [FL-no: 16.048] and diammoniun sulfide [FL-no: 16.002] would present 
no safety concern at the levels of intakes estimated on the basis of the MSDI approach. 
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BACKGROUND 
Regulation (EC) No 2232/96 of the European Parliament and the Council (EC, 1996a) lays down a 
Procedure for the establishment of a list of flavouring substances the use of which will be authorised 
to the exclusion of all other substances in the EU. In application of that Regulation, a Register of 
flavouring substances used in or on foodstuffs in the Member States was adopted by Commission 
Decision 1999/217/EC (EC, 1999a), as last amended by Commission Decision 2009/163/EC (EC, 
2009a). Each flavouring substance is attributed a FLAVIS-number (FL-number) and all substances are 
divided into 34 chemical groups. Substances within a group should have some metabolic and 
biological behaviour in common. 
Substances which are listed in the Register are to be evaluated according to the evaluation programme 
laid down in Commission Regulation (EC) No 1565/2000 (EC, 2000a), which is broadly based on the 
Opinion of the Scientific Committee on Food (SCF, 1999a). For the submission of data by the 
manufacturer, deadlines have been established by Commission Regulation (EC) No 622/2002 (EC, 
2002b).  
The FGE is revised to include substances for which data were submitted after the deadline as laid 
down in Commission Regulation (EC) No 622/2002 and to take into account additional information 
that has been made available since the previous Opinion on this FGE.  
The Revision also includes newly notified substances belonging to the same chemical groups 
evaluated in this FGE. 
After the completion of the evaluation programme the Union List of flavouring substances for use in 
or on foods in the EU shall be adopted (Article 5 (1) of Regulation (EC) No 2232/96) (EC, 1996a). 
HISTORY OF THE EVALUATION  
FGE Opinion 
adopted by 
EFSA 
Link No. of 
candidate 
substances 
FGE.46 March 2008 http://www.efsa.europa.eu/en/scdocs/scdoc/955.htm 3 
FGE.46Rev1 November 
2010 
 4 
 
The present Revision of FGE.46, FGE.46Rev1, includes the assessment of one additional candidate 
substance, diammonium sulfide [FL-no: 16.002]. No toxicity and/or metabolism data were provided 
for this substance (Flavour Industry, 2009p). A literature search for this substance did not provide any 
further data on toxicity or metabolism.  
 
Furthermore, additional information on the specifications requested in FGE.46 have become available 
for two substances. These data have been included in the present FGE as well. 
TERMS OF REFERENCE 
The European Food Safety Authority (EFSA) is requested to carry out a risk assessment on flavouring 
substances in the Register prior to their authorisation and inclusion in a Union List according to 
Commission Regulation (EC) No 1565/2000 (EC, 2000a). In addition, the Commission requested 
EFSA to evaluate newly notified flavouring substances, where possible, before finalising the 
evaluation programme. 
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ASSESSMENT 
1. Presentation of the Substances in Flavouring Group Evaluation 46, Revision 1 
1.1. Description 
The present Flavouring Group Evaluation 46, Revision 1 (FGE.46, Rev1), using the Procedure as 
referred to in the Commission Regulation (EC) No 1565/2000 (EC, 2000a) (The Procedure – shown in 
schematic form in Annex I), deals with ammonia and three ammonium salts. These four flavouring 
substances (candidate substances) belong to chemical group 30, Annex I of Commission Regulation 
(EC) No 1565/2000 (EC, 2000a). The four candidate substances, their chemical Register names, 
FLAVIS- ( FL-), Chemical Abstract Service- (CAS-), Council of Europe- (CoE-) and Flavor and 
Extract Manufacturers Association- (FEMA-) numbers, structure and specifications, are listed in Table 
1. This group of candidate substances includes diammonium sulphide [FL-no: 16.002], ammonia [FL-
no: 16.009], ammonium chloride [FL-no: 16.048] and ammonium hydrogen sulfide [FL-no: 16.059]. 
The Joint FAO/WHO Expert Committee on Food Additives (the JECFA) evaluated ammonium 
carbonate and ammonium hydrogen carbonate in 1982 (JECFA, 1982a). Because toxicological studies 
were limited for these compounds, data on related ammonium salts (primarily ammonium chloride) 
and carbonate salts (primarily sodium and potassium carbonate and hydrogen carbonate (bicarbonate)) 
were also summarised and discussed. An acceptable daily intake (ADI) in mg/kg body weight (bw) 
was not deemed necessary: “ADI not specified”.  
The SCF made an recommendation on ammonium chloride in liquorice products in an Opinion 
expressed on 11 October 1991 (SCF, 1992), in which the SCF concluded that it is not possible to 
allocate an acceptable daily intake (ADI) to ammonium chloride as no data are available to establish a 
no adverse effect level for the ingestion of ammonium chloride.  
The outcome of the safety evaluation is summarised in table 2. 
1.2. Stereoisomers 
The candidate substances cannot exist as geometrical or optical isomers. 
1.3. Natural Occurrence in Food 
Ammonia [FL-no: 16.009] and hydrogen sulphide (from ammonium hydrogen sulfide [FL-no: 16.059] 
and diammonium sulphide [FL-no: 16.002) have been reported to occur naturally in apple, banana, 
barley, beef, beer, beetroot, butter, cabbage, carrot, cauliflower, caviar, celery, cheese, chicken, coffee, 
sweet corn, egg, fish (fatty, lean), fruit juice, hop oil, kale, lettuce, malt, milk, mushroom, onion, pork, 
potato chips, radish, rhubarb, rice, rutabaga, shrimps, soybean, squid, black tea, tomato, wasabi and 
wine (TNO, 2000; TNO, 2010).  
Quantitative data on the natural occurrence in food reported include (TNO, 2000; TNO, 2010): 
• Ammonia [FL-no: 16.009]/ammonium ion: 235 mg/kg in fresh apple, 8130 mg/kg in barley, 8800 
mg/kg in beetroot, up to 11060 mg/kg in cooked cabbage, 3970 mg/kg in carrot, 6376 mg/kg in 
cauliflower, 19600 mg/kg in celery leaves and/or stalks, 164400 mg/kg in tilsit cheese, 0.2 mg/kg 
in fried chicken, up to 820 mg/kg in coffee, 10030 mg/kg in sweet corn, up to 9 mg/kg in egg, up to 
2928 mg/kg in fish (fatty, salted), 10660 mg/kg in hop oil, 15260 mg/kg in kale, 10260 mg/kg in 
lettuce, 1192 mg/kg in malt, 8450 mg/kg in radish (raw), 6340 mg/kg in rhubarb, 400 mg/kg in 
black tea, up to 40 mg/kg in red wine and up to 69 mg/kg in white wine. 
H2S/HS- ion: up to 0.004 mg/kg in beer, up to 0.002 mg/kg in butter, up to 0.8 mg/kg in cheese, up 
to 1.7 mg/kg in chicken, up to 0.2 mg/kg in sweet corn, up to 1.5 mg/kg in egg, trace amount in 
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grapefruit juice, up to 0.0005 mg/kg in milk, 0.01 mg/kg in mushroom, up to 0.03 mg/kg in orange 
juice, trace amount in soybean and up to 0.1 mg/kg in strawberry.  
According to TNO, the diammonium sulphide [FL-no: 16.002] has not been reported in any food 
items (TNO, 2010). 
2. Specifications 
Purity criteria for the four substances have been provided by the Flavour Industry (EFFA, 2006g; 
Flavour Industry, 2009p) (Table 1). 
Judged against the requirements in Annex II of Commission Regulation (EC) No 1565/2000 (EC, 
2000), the purity criteria for one of the candidate substances are deficient in one of the parameters as 
the identification test is missing. Otherwise the specifications are adequate for all four candidate 
substances (see Section 1.2 and Table 1). 
3. Intake Data 
Annual production volumes of the flavouring substances as surveyed by the Industry can be used to 
calculate the “Maximised Survey-derived Daily Intake” (MSDI) by assuming that the production 
figure only represents 60 % of the use in food due to underreporting and that 10 % of the total EU 
population are consumers (SCF, 1999a). 
However, the Panel noted that due to year-to-year variability in production volumes, to uncertainties 
in the underreporting correction factor and to uncertainties in the percentage of consumers, the 
reliability of intake estimates on the basis of the MSDI approach is difficult to assess. 
The Panel also noted that in contrast to the generally low per capita intake figures estimated on the 
basis of this MSDI approach, in some cases the regular consumption of products flavoured at use 
levels reported by the Flavour Industry in the submissions would result in much higher intakes. In 
such cases, the human exposure thresholds below which exposures are not considered to present a 
safety concern might be exceeded. 
Considering that the MSDI model may underestimate the intake of flavouring substances by certain 
groups of consumers, the SCF recommended also taking into account the results of other intake 
assessments (SCF, 1999a). 
One of the alternatives is the “Theoretical Added Maximum Daily Intake” (TAMDI) approach, which 
is calculated on the basis of standard portions and upper use levels (SCF, 1995) for flavourable 
beverages and foods in general, with exceptional levels for particular foods. This method is regarded 
as a conservative estimate of the actual intake by most consumers because it is based on the 
assumption that the consumer regularly eats and drinks several food products containing the same 
flavouring substance at the upper use level. 
One option to modify the TAMDI approach is to base the calculation on normal rather than upper use 
levels of the flavouring substances. This modified approach is less conservative (e.g., it may 
underestimate the intake of consumers being loyal to products flavoured at the maximum use levels 
reported) (EC, 2000a). However, it is considered as a suitable tool to screen and prioritise the 
flavouring substances according to the need for refined intake data (EFSA, 2004a). 
3.1. Estimated Daily per Capita Intake (MSDI Approach) 
The intake estimation is based on the Maximised Survey-derived Daily Intake (MSDI) approach, 
which involves the acquisition of data on the amounts used in food as flavourings (SCF, 1999a). These 
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data are derived from surveys on annual production volumes in Europe. These surveys were conducted 
in 1995 by the International Organization of the Flavour Industry, in which flavour manufacturers 
reported the total amount of each flavouring substance incorporated into food sold in the EU during 
the previous year (IOFI, 1995). The intake approach does not consider the possible natural occurrence 
in food. 
Average per capita intake (MSDI) is estimated on the assumption that the amount added to food is 
consumed by 10 % of the population4 (Eurostat, 1998). This is derived for candidate substances from 
estimates of annual volume of production provided by Industry and incorporates a correction factor of 
0.6 to allow for incomplete reporting (60 %) in the Industry surveys (SCF, 1999a). 
In the present Flavouring Group Evaluation, Revision 1 (FGE.46Rev1) the total annual production 
volume of the four candidate substances for use as flavouring substances in Europe was reported to be 
approximately 2000 kg (EFFA, 2006g; Flavour Industry, 2009p). The daily per capita intakes for the 
candidate substances are 62 microgram (diammonium sulphide, [FL-no: 16.002]), 140 microgram 
(ammonium chloride, [FL-no: 16.048]), 34 microgram (ammonia, [FL-no: 16.009] and 5.6 microgram 
(ammonium hydrogen sulphide, [FL-no: 16.059]) (Table 2). 
3.2. Intake Estimated on the Basis of the Modified TAMDI (mTAMDI) 
The method for calculation of modified Theoretical Added Maximum Daily Intake (mTAMDI) values 
is based on the approach used by SCF up to 1995 (SCF, 1995). 
The assumption is that a person may consume a certain amount of flavourable foods and beverages per 
day. 
For the present evaluation of the four candidate substances, information on food categories and normal 
and maximum use levels5,6,7 were submitted by the Flavour Industry (EFFA, 2006g; EFFA, 2007a) 
only for three of the four candidate substances. The four candidate substances are used in flavoured 
food products divided into the food categories, outlined in Annex III of the Commission Regulation 
(EC) No 1565/2000 (EC, 2000a), as shown in Table 3.1. For the present calculation of mTAMDI, the 
reported normal use levels were used. In case different use levels were reported for different food 
categories the highest reported normal use level was used.  
For diammonium sulphide, [FL-no: 16.002] no use and use levels have been reported by Industry. 
                                                     
 
4 EU figure 375 millions. This figure relates to EU population at the time for which production data are 
available, and is consistent (comparable) with evaluations conducted prior to the enlargement of the EU. No 
production data are available for the enlarged EU. 
5 ”Normal use” is defined as the average of reported usages and ”maximum use” is defined as the 95th percentile 
of reported usages (EFFA, 2002i). 
6 The normal and maximum use levels in different food categories (EC, 2000) have been extrapolated from 
figures derived from 12 model flavouring substances (EFFA, 2004e). 
7 The use levels from food category 5 “Confectionery” have been inserted as default values for food category 
14.2 “Alcoholic beverages” for substances for which no data have been given for food category 14.2 (EFFA, 
2007a). 
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Table 3.1 Use of Candidate Substances, for which Industry has Provided Data on Food Categories and 
Normal and Maximum Use Levels (three of the four Candidate Substances) 
Food 
category 
Description Flavourings used 
01.0 Dairy products, excluding products of category 2 All three 
02.0 Fats and oils, and fat emulsions (type water-in-oil) Only [FL-no: 16.059] 
03.0 Edible ices, including sherbet and sorbet Only [FL-no: 16.059] 
04.1 Processed fruits Only [FL-no: 16.059] 
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and 
legumes), and nuts & seeds 
None 
05.0 Confectionery All three 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses 
& legumes, excluding bakery 
Only [FL-no: 16.059] 
07.0 Bakery wares Only [FL-no: 16.059] 
08.0 Meat and meat products, including poultry and game All three 
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  All three 
10.0 Eggs and egg products None 
11.0 Sweeteners, including honey None 
12.0 Salts, spices, soups, sauces, salads, protein products etc. All three 
13.0 Foodstuffs intended for particular nutritional uses Only [FL-no: 16.059] 
14.1 Non-alcoholic ("soft") beverages, excl. dairy products Only [FL-no: 16.059] 
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts All three 
15.0 Ready-to-eat savouries Only [FL-no: 16.059] 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not 
be placed in categories 1 – 15 
All three 
 
According to the Flavour Industry the normal use levels for the three candidate substances, for which 
use levels have been provided, are in the range of 0.1 - 1000 mg/kg food, and the maximum use levels 
are in the range of 1 - 3000 mg/kg (EFFA, 2002i; EFFA, 2006g; EFFA, 2007a).  
The mTAMDI values for the two candidate substances, ammonia and ammonium chloride [FL-no: 
16.009 and 16.048] from structural class I are 110000 and 220000 microgram/person/day, 
respectively. For the third candidate substance, ammonium hydrogen sulfide [FL-no: 16.059] from 
structural class III (see Section 5) the mTAMDI is 220 microgram/person/day. No use levels have 
been provided for [FL-no: 16.002]. 
For detailed information on use levels and intake estimations based on the mTAMDI approach, see 
Section 6 and Annex II. 
4. Absorption, Distribution, Metabolism and Elimination 
Ammonia and ammonium ion are present in aqueous environment at different ratios depending on the 
pH. 
Ammonia is produced endogenously in all mammalian species. In the gut ammonia is produced by 
bacterial degradation of nucleic and amino acids from ingested food. The estimated production of 
ammonia in the human intestine may range from 10 mg/day in the duodenum to 3 g/day in the colon. 
Ammonia is readily absorbed from the gastro-intestinal tract, after which it enters the portal circulation 
and is transformed to urea in the liver via the urea cycle, and is subsequently excreted as urea via the 
kidneys. Ammonium chloride is easily absorbed.  
Ammonium hydrogen sulphide and diammonium sulphide are expected to give rise to ammonium ion 
and hydrogen sulphide in the stomach and to be rapidly absorbed.  
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Hydrogen sulphide is also endogenously produced. The main source is from metabolism of sulphur-
containing amino acids in the intestinal tract; other sources are bacterial reduction of inorganic 
sulphate and sulphite in the large intestine and fermentation of sulphur-containing amino acids. 
Sulphide concentrations in whole blood ranged from 10 – 100 micromol/l (corresponding to 320 – 
3200 microgram/l) in six healthy adults (Richardson et al., 2000). The major pathway for sulphide 
metabolism is oxidation to sulphate and excretion by the kidneys. The primary location for these 
reactions is the liver. There is an intestinal enzymatic detoxification system for endogenously 
produced sulphide that may take care of the low amounts of hydrogen sulphide that may be ingested as 
flavouring substance. 
All four candidate substances may therefore be predicted to be metabolised to innocuous products at 
the estimated levels of exposure as flavouring substances, according to the MSDI approach.  
A more detailed discussion of the metabolism of the candidate substances in this evaluation is 
provided in Annex III. 
5. Application of the Procedure for the Safety Evaluation of Flavouring Substances 
The application of the Procedure is based on intakes estimated on the basis of the MSDI approach. 
Where the mTAMDI approach indicates that the intake of a flavouring substance might exceed its 
corresponding threshold of concern, a formal safety assessment is not carried out using the Procedure. 
In these cases the Panel requires more precise data on use and use levels. For comparison of the intake 
estimations based on the MSDI approach and the mTAMDI approach, see Section 6. 
For the safety evaluation of the four candidate substances from chemical group 30 the Procedure as 
outlined in Annex I was applied, based on the MSDI approach. The stepwise evaluations of the four 
substances are summarised in Table 2. 
Step 1 
The candidate substances are classified according to the decision tree approach by Cramer et al. 
(Cramer et al, 1978). Two substances are classified into structural class I [FL-no: 16.009 and 16.048] 
and two into structural class III [FL-no: 16.002 and 16.059].  
Step 2 
On the basis of the metabolism information the two candidate substances, ammonia and ammonium 
chloride [FL-no: 16.009 and 16.048] in structural class I may be predicted to be metabolised to 
innocuous products, and their evaluation will proceed via the A-side of the Procedure scheme.  
The two substances belonging to structural class III, diammonium sulphide [FL-no: 16.002] and 
ammonium hydrogen sulphide [FL-no: 16.059] may also be predicted to be metabolised to innocuous 
products, and accordingly their evaluation proceeds via the A-side of the Procedure scheme.  
Step A3 
The two candidate substances [FL-no: 16.009 and 16.048] assigned to structural class I have estimated 
European daily per capita intakes (MSDI) of 34 and 140 microgram, respectively (Table 6.1). These 
intakes are below the threshold of concern of 1800 microgram/person/day for structural class I.  
The two candidate substances [FL-no: 16.002 and 16.059] assigned to structural class III have 
estimated daily per capita intake (MSDI) of 62 and 5.6 microgram, respectively (Table 6.1). These 
intakes are below the threshold of concern of 90 microgram/person/day for structural class III.  
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Based on the results of the safety evaluation sequence of the Procedure, these four candidate 
substances proceeding via the A-side of the Procedure scheme do not pose a safety concern when used 
as flavouring substances, based on the MSDI approach. 
6. Comparison of the Intake Estimations Based on the MSDI Approach and the mTAMDI 
Approach 
The estimated intakes for the two candidate substances [FL-no: 16.009 and 16.048] in structural class I 
based on the mTAMDI, are 110000 and 220000 microgram/person/day, respectively. For these two 
substances the mTAMDI is above the threshold of concern of 1800 microgram/person/day. For 
comparison of the intake estimates based on the MSDI approach and the mTAMDI approach see Table 
6.1.  
The estimated intake of the third substance [FL-no: 16.059] assigned to structural class III, based on 
the mTAMDI, is 220 microgram/person/day, which is above the threshold of concern for structural 
class III substances of 90 microgram/person/day. For comparison of the MSDI- and mTAMDI-values, 
see Table 6.1. 
The estimated intake of [FL-no: 16.002] assigned to structural class III, cannot be calculated as 
Industry has not provided information on use and use levels. 
For all the candidate substances further information is required. This would include more reliable 
intake data and then, if required, additional toxicological data. 
 
Table 6.1 Estimated intakes based on the MSDI approach and the mTAMDI approach 
FL-no EU Register name MSDI 
(μg/capita/day) 
mTAMDI 
(μg/person/day) 
Structural 
class 
Threshold of concern 
(µg/person/day) 
16.009 Ammonia 34 110000 Class I 1800 
16.048 Ammonium chloride 140 220000 Class I 1800 
16.002 Diammonium sulfide 62  Class III 90 
16.059 Ammonium hydrogen sulphide 5.6 220 Class III 90 
7. Considerations of Combined Intakes from Use as Flavouring Substances 
The total estimated combined daily per capita intake of structurally related flavourings is estimated by 
summing the MSDI for individual substances. 
The combined intake of the two candidate substances [FL-no: 16.009 and 16.048] from structural class 
I is approximately 170 microgram/capita/day, which is below the threshold of concern of 1800 
microgram/person/day for structural class I substances. 
The combined intake of the two candidate substances [FL-no: 16.002 and 16.059] from structural class 
III is approximately 70 microgram/capita/day, which is below the threshold of concern of 90 
microgram/person/day for structural class III substances. 
8. Toxicity 
8.1. Acute Toxicity 
An oral LD50 of 1650 mg/kg body weight (bw) has been reported for the candidate substance 
ammonium chloride [FL-no: 16.048] in the rat (IUCLID Dataset, 2000d). 
The acute toxicity data are summarised in Annex IV, Table IV.1. 
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8.2. Subacute, Subchronic, Chronic and Carcinogenicity Studies 
Studies on only one candidate substance, ammonium chloride [FL-no: 16.048], have been submitted. 
Ammonium chloride has not been tested per se, but has been used to produce metabolic acidosis, and 
the aim of most studies has been to study the effect of acidosis on different parameters. 
In studies designed to examine the effects of feeding an acidogenic diet to rats, ammonium chloride 
[FL-no: 16.048] was fed to rats for periods of 4 weeks, 13 weeks (approx. 1.6-3.7 g/kg bw/day) or 18 
months (approx. 0.5-1.4 g/kg bw/day). A carcinogenicity study of 30 months (approx. 0.5-1.2 g/kg 
bw/day) was also conducted. All animals fed NH4Cl had reduced urinary pH. Clinical condition and 
death rate were not affected by treatment. Growth retardation was noted in the high treatment group, 
and in females of the low treatment group. Urinary calcium and phosphorus excretion was increased in 
treatment groups, but there was no indication that bone minerals were involved. Kidney weights were 
increased in all ammonium chloride-treated animals. Hypertrophy of the adrenal zona glomerulosa 
occurred, due to chronic stimulation of the adrenal cortex by treatment-induced acidosis. No 
treatment-related changes in any specific tumour type were noted among treated animals. It was not 
possible to derive a No Observed Adverse Effect Level (NOAEL) from these studies. The 30 month 
carcinogenicity study gave no indication that the feeding of ammonium chloride to rats at dose levels 
of approximately 0.5-1.2 g/kg bw/day would induce tumours (Lina & Kuijpers, 2004 ). 
Dietary levels of 3 g/kg bw per day ammonium chloride [FL-no: 16.048] for 6 days gave rise to renal 
hypertrophy in rats (Thompson & Halliburton, 1966). The same effect occurred when ammonium 
chloride [FL-no: 16.048] was given ad libitum in drinking water for 7 days, and approximately 1 g/kg 
bw/day was ingested. No increase occurred in uptake of tritiated thymidine in the kidney, implying 
that no cell division or DNA synthesis occurred (Lotspeich, 1965).  
Rats receiving 1.5 % (corresponding to approximately 1.5 g/kg bw) ammonium chloride [FL-no: 
16.048]/kg bw/day in drinking water for 330 days showed significant loss of bone tissue. Changes 
were independent of dietary Ca, and not associated with blood Ca or P. Rats that received 2 % of the 
same compound in drinking water for 6 months showed significant reduction in bone density, which 
was accentuated by a low-Ca-diet (Barzel, 1969; Barzel & Jowsey, 1969). 
Although the available data do not allow the identification of a NOAEL, high dose levels were used to 
study effects of ammonium chloride in several animal species (1-4 g/kg bw). The results support the 
conclusion of the endogenous production of ammonia. 
No studies have been submitted on the candidate substances ammonium hydrogen sulphide [FL-no: 
16.059] and diammonium sulphide [FL-no: 16.002] or on structurally related flavouring substances. 
However, it is structurally related to hydrogen sulphide, which is considered below. 
The mechanism of toxicity of hydrogen sulphide is the inhibition of cytochrome oxidase and through 
this, the inhibition of the electron transport system.  
In a U.S. Environmental Protection Agency’s toxicological review on hydrogen sulphide (EPA, 2003) 
a 90-day study on rats is described. This study by Anderson was reported in 1987 and is not publicly 
available. According to the description of the study, hydrogen sulphide (presumably as solution, 
vehicle not known) was given by gavage to groups of 20 rats daily for 89 days in doses of 0, 1, 3.5 or 
7 mg/kg bw per day. For preparation of hydrogen sulphide solution, hydrogen sulphide was purged 
through deoxygenated, deionised water. The solution was stored in sealed vials and fresh vials were 
used at each administration. Blood samples were collected at days 27-31 of treatment and at necropsy. 
Animals were subjected to full necropsy and extensive microscopical examination. Mortality was 50 
% in high-dose males compared to 5 % in control males, cause of death in the high dose group was, 
however, not determined. No deaths were observed in high-dose females. Compound-related 
neuromuscular and behavioral signs were observed in high-dose male and female animals. There were 
no treatment-related effects in hematology or clinical chemistry nor in body weights. 
Ophthalmological findings were normal. The most common findings at necropsy were red mottled 
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lungs. No gross lesions could be attributed to compound administration and all microscopic findings 
were considered incidental to compound administration. However, the information indicates 
procedural problems with the dosing of the animals; a 75-100 % incidence of pneumonia was reported 
in vehicle control and treatment groups whereas 0 % incidence of pneumonia was reported for the 
non-gavaged control group. According to the EPA evaluation, the lack of quality assurance precludes 
the use of this study for derivation of a NOEL (EPA, 2003).  
In WHO drinking water guidelines (WHO, 1996) the oral dose of sodium sulphide fatal to humans (60 
kg) has been estimated at 10-15 g. For drinking water no health guideline is proposed. The 
organoleptic threshold for hydrogen sulphide in drinking water is < 0.05 mg/l, and it is stated that the 
quantity of sulphide ingested from drinking water containing sulphide at this concentration is well 
below the amount that the body can detoxify. 
Conclusions on toxicity 
From the available toxicity data it is not possible to derive NOAELs for the candidate substances. 
However, ammonia and hydrogen sulphide are substances that are formed endogenously in the body at 
levels much higher than what can be formed from use of the candidate substances at the estimated 
levels of exposure (6 – 140 microgram/ capita/ day based on the MSDI approach) and for which the 
body has intrinsic detoxification systems. Data on metabolism and kinetics (see Section 4 and Annex 
III) along with the available information on toxicity give clear indication that the amounts of the 
candidate substances that may be ingested from the use as flavourings, according to the MSDI 
approach, do not raise concern with respect to toxicity. 
Repeated dose toxicity data are summarised in Annex IV, Table IV.2. 
8.3. Developmental / Reproductive Toxicity Studies 
No studies on developmental or reproductive toxicity have been submitted for any of the candidate 
substances. Developmental toxicity studies in rats exposed to hydrogen sulphide via the inhalational 
route throughout gestation showed no adverse effects in the embryo or foetus, nor in offspring during 
postnatal development, at exposures up to 80 ppm (for review, see (US ATSDR, 2006)) For ammonia 
(actually ammonium ion) an oral developmental toxicity study has been reported (for review, see (US 
ATSDR, 2004)), but the effect (reduced body weight gain in off-spring) was observed at such high 
dose levels (> 4000 mg/kg bw/day) that the effects in the offspring were most likely the result of 
maternal toxicity. 
8.4. Genotoxicity Studies 
Ammonia gas at concentrations of 500-25000 ppm has been reported to give a negative result in a 
bacterial mutagenicity assay using Salmonella typhimurium sp. TA98, TA100, TA1535, TA1537 and 
TA1538 in the presence and absence of metabolic activation (Shimoi et al., 1985). Tests using 
Escherichia Coli WRP uvrA were also negative (Shimoi et al., 1985).  
There are very limited in vivo mammalian data on the effects of ammonia. A mouse micronucleus test 
(single intraperitoneal dose of ammonium at 12, 25 or 50 mg/kg bw) reported dose dependent 
increases in the frequencies of micronuclei when compared to controls (Yadav & Kaushik, 1997). Few 
details were given and no conclusions can be drawn. Slight mutagenic activity has been reported in 
Drosophila following exposure to ammonia gas, but only at very toxic levels (US ATSDR, 2004).  
Ammonium chloride at concentrations up to 10 mg/plate has been reported to give negative results in a 
bacterial mutation assay using S. typhimurium strains TA92, TA94, TA98, TA100, TA1535 and 
TA1537 (Ishidate et al., 1984; Ishidate et al., 1988). Ammonium chloride in the absence of metabolic 
activation caused an increase in the incidence of cells with structural chromosomal aberrations 
(including gaps) in Chinese hamster fibroblasts, which the authors suggested were due to osmotic 
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effects rather than a direct interaction with DNA (Ishidate et al., 1984; Ishidate et al., 1988). In vivo, 
ammonium chloride did not induce an increase in the incidence of micronucleated polychromatic 
erythrocytes obtained from the bone marrow of male ddY mice, 24 hours after one intraperitoneal 
injection of 62.5-500 mg/kg bw or four intraperitoneal injections of 31.3-250 mg/kg bw (Hayashi et 
al., 1988).  
Ammonium sulphate has also been reported to give negative results in bacterial mutagenicity tests but 
to enhance the frequency of chromosome type aberrations (UNEP, 2004). A similar effect has 
however been observed with other salts (magnesium chloride, calcium chloride and sodium chloride), 
and is considered to be linked to osmotic effects rather than being indicative of a clastogenic effect of 
ammonium sulphate or the ammonium ion. 
No genotoxicity studies are available on ammonium hydrogen sulphide. No mutagenicity was 
observed with hydrogen sulfide gas in Ames assays using S. typhimurium TA97, TA98, and TA100 
strains in the presence and absence of metabolic activation (US ATSDR, 2006).  
Conclusion on genotoxicity 
Overall, the genotoxicity data available do not preclude an evaluation of the four substances through 
the Procedure. 
Genotoxicity data are summaries in Annex IV, Table IV.4 and Table IV.5. 
9. Conclusions 
The present Flavouring Group Evaluation deals with ammonia [FL-no: 16.009], and three ammonia 
salts (diammonium sulphide [FL-no: 16.002], ammonium chloride [FL-no: 16.048] and ammonium 
hydrogen sulphide [FL-no: 16.059]). 
The flavouring substances cannot exist as geometrical or optical isomers. 
Two of the flavouring substances are classified into structural class I and two are classified into 
structural class III according to the decision tree approach presented by Cramer et al. (1978). 
The flavouring substance ammonia in the present group has been reported to occur naturally in a wide 
range of food items up to very high amounts. Hydrogen sulphide is also reported to occur naturally in 
a wide range of food items. 
In its evaluation, the Panel as a default used the Maximised Survey-derived Daily Intake (MSDI) 
approach to estimate the per capita intakes of the flavouring substances in Europe. However, when the 
Panel examined the information provided by the European Flavour Industry on the use levels in 
various foods, it appeared obvious that the MSDI approach in a number of cases would grossly 
underestimate the intake by regular consumers of products flavoured at the use level reported by the 
Industry, especially in those cases where the annual production values were reported to be small. In 
consequence, the Panel had reservations about the data on use and use levels provided and the intake 
estimates obtained by the MSDI approach. 
In the absence of more precise information that would enable the Panel to make a more realistic 
estimate of the intakes of the flavouring substances, the Panel has decided also to perform an estimate 
of the daily intakes per person using a modified Theoretical Added Maximum Daily Intake 
(mTAMDI) approach based on the normal use levels reported by Industry. In those cases where the 
mTAMDI approach indicated that the intake of a flavouring substance might exceed its corresponding 
threshold of concern, the Panel decided not to carry out a formal safety assessment using the 
Procedure. In these cases the Panel requires more precise data on use and use levels. 
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According to the default MSDI approach, the two flavouring substances [FL-no: 16.009 and 16.048] 
belonging to structural class I have estimated intakes in Europe of 34 and 140 microgram/capita/day, 
respectively, which are below the threshold of concern for structural class I substances (1800 
microgram/person/day). The two substances belonging to structural class III have estimated intake in 
Europe of 62 and 5.6 microgram/capita/day, respectively, which is below the threshold of concern for 
structural class III substances (90 microgram/person/day). 
Although the genotoxicity data for the flavouring substances in this group are limited, the available 
data on genotoxicity do not preclude an evaluation of the candidate substances through the Procedure. 
For the candidate substance ammonium chloride [FL-no: 16.048] there is a well-performed 
carcinogenicity study available, which indicates that the substance does not induce tumours. 
Ammonia is a substance that is readily absorbed in the gut. It is produced endogenously in amounts 
that far exceed those that are to be ingested as flavourings. The three ammonium salts are expected to 
give rise to ammonium ion and chloride or hydrogen sulphide. Ammonia is expected to be transported 
by the portal circulation to the liver and metabolised to urea by the Krebs urea cycle and subsequently 
excreted by the kidneys. Hydrogen sulphide is a substance that is produced endogenously. The major 
pathway for sulphide metabolism is oxidation to sulphate and excretion by the kidney. The major 
oxidation product of sulphide is thiosulphate which is then converted to sulphate. The primary location 
for these reactions is the liver. All four substances are accordingly expected to be metabolised to 
innocuous substances at the anticipated levels of intake as flavouring substances.  
It was noted that where toxicity data were available they were consistent with the conclusions in the 
present flavouring group evaluation using the Procedure. 
On the basis of the default MSDI approach the Panel concluded that the flavouring substances would 
not give rise to safety concerns at the estimated levels of intake arising from their use as flavouring 
substances. 
When the estimated intakes were based on the mTAMDI approach the values for the two substances 
from structural class I, ammonia and ammonium chloride [FL-no: 16.009 and 16.048], are 110000 
microgram/person/day and 220000 microgram/person/day, respectively. These values are above the 
threshold of concern for structural class I of 1800 microgram/person/day. For one of the substances 
from structural class III, ammonium hydrogen sulphide [FL-no: 16.059], the mTAMDI value is 220 
microgram/person/day. This value is above the threshold for structural class III of 90 
microgram/person/day. For the other substance from structural class III no data are available on use 
and use levels.  
Thus, intake estimates based on the mTAMDI approach exceed the threshold of concern for the three 
flavouring substances in this flavouring group, and more reliable exposure data are requested for all 
four. On the basis of such additional data, these flavouring substances should be reconsidered using 
the Procedure. Subsequently, additional data might become necessary. 
In order to determine whether this evaluation could be applied to the materials of commerce, it is 
necessary to consider the available specifications. Specifications including complete purity criteria for 
the materials of commerce have been provided for the four flavouring substances.  
Identity test is missing for one of the flavouring substances, ammonium hydrogen sulphide [FL-no: 
16.059]. Thus, the final evaluation of the materials of commerce cannot be performed for this  
substance, pending further information. The remaining three flavouring substances, ammonia [FL-no: 
16.009], ammonium chloride [FL-no: 16.048] and diammoniun sulfide [FL-no: 16.002] would present 
no safety concern at the levels of intakes estimated on the basis of the MSDI approach. 
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TABLE 1: SPECIFICATION SUMMARY OF THE SUBSTANCES IN THE FLAVOURING GROUP EVALUATION 46, REVISION 1 
Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 46, Revision 1 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification comments 
16.002 
 
Diammonium sulfide (NH4)2S  2053 482 
12135-76-1 
Liquid 
H8N2S 
68.15 
Soluble 
Freely soluble 
40 
 
IR 
95 % 
1.378-1.398 
0.995-0.999 
 
 
16.009 
 
Ammonia NH3  739 
7664-41-7 
Gas 
H3N 
17.03 
Soluble 
Freely soluble 
n.a. 
n.a. 
 
95 % 
n.a. 
n.a. 
Physical form: Gas. ID test 
not applicable. 
16.048 
 
Ammonium chloride NH4+, Cl-  
 
 
12125-02-9 
Solid 
H4NCl 
53.49 
Very soluble 
Freely soluble 
 
decomposes 
 
99 % 
n.a. 
n.a. 
ID test not applicable. 
16.059 
 
Ammonium hydrogen sulphide NH4+, HS-  
2053 
482 
12124-99-1 
Liquid 
H5NS 
51.11 
Soluble 
Freely soluble 
40 
 
 
95 % 
1.378-1.398 
0.995-0.999 
ID 6) 
 
1) Solubility in water, if not otherwise stated. 
2) Solubility in  95 %  ethanol, if not otherwise stated. 
3) At 1013.25 hPa, if not otherwise stated. 
4) At 20°C, if not otherwise stated. 
5) At 25°C, if not otherwise stated. 
6) ID: Missing identification test. 
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TABLE 2: SUMMARY OF SAFETY EVALUATION APPLYING THE PROCEDURE (BASED ON INTAKES CALCULATED BY THE MSDI APPROACH) 
Table 2: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5] 
Outcome on the 
material of 
commerce [6), 7), 
or 8)] 
Evaluation remarks 
16.009 
 
Ammonia NH3 34  
Class I 
A3: Intake below threshold 
4) 7)  
16.048 
 
Ammonium chloride NH4+, Cl-  
140 
 
Class I 
A3: Intake below threshold 
4) 7)  
16.002 
 
Diammonium sulfide (NH4)2S  62  
Class III 
A3: Intake below threshold 
4) 7)  
16.059 
 
Ammonium hydrogen sulphide NH4+, HS-  
5.6 
 
Class III 
A3: Intake below threshold 
4) 6)  
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Thresholds of concern: Class I = 1800, Class II = 540, Class III = 90 µg/person/day. 
3) Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
6) No safety concern at estimated level of intake of the material of commerce meeting the specification of Table 1 (based on intake calculated by the MSDI approach). 
7) Tentatively regarded as presenting no safety concern (based on intake calculated by the MSDI approach) pending further information on the purity of the material of commerce and/or information on stereoisomerism. 
8) No conclusion can be drawn due to lack of information on the purity of the material of commerce. 
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ANNEX I: PROCEDURE FOR THE SAFETY EVALUATION 
The approach for a safety evaluation of chemically defined flavouring substances as referred to in 
Commission Regulation (EC) No 1565/2000 (EC, 2000a), named the "Procedure", is shown in schematic 
form in Figure I.1. The Procedure is based on the Opinion of the Scientific Committee on Food expressed on 
2 December 1999 (SCF, 1999a), which is derived from the evaluation Procedure developed by the Joint 
FAO/WHO Expert Committee on Food Additives at its 44th, 46th and 49th meetings (JECFA, 1995; JECFA, 
1996a; JECFA, 1997a; JECFA, 1999b). 
The Procedure is a stepwise approach that integrates information on intake from current uses, structure-
activity relationships, metabolism and, when needed, toxicity. One of the key elements in the Procedure is 
the subdivision of flavourings into three structural classes (I, II, III) for which thresholds of concern (human 
exposure thresholds) have been specified. Exposures below these thresholds are not considered to present a 
safety concern. 
Class I contains flavourings that have simple chemical structures and efficient modes of metabolism, which 
would suggest a low order of oral toxicity. Class II contains flavourings that have structural features that are 
less innocuous, but are not suggestive of toxicity. Class III comprises flavourings that have structural 
features that permit no strong initial presumption of safety, or may even suggest significant toxicity (Cramer 
et al., 1978). The thresholds of concern for these structural classes of 1800, 540 or 90 microgram/person/day, 
respectively, are derived from a large database containing data on subchronic and chronic animal studies 
(JECFA, 1996a). 
In Step 1 of the Procedure, the flavourings are assigned to one of the structural classes. The further steps 
address the following questions: 
• can the flavourings be predicted to be metabolised to innocuous products8 (Step 2)?  
• do their exposures exceed the threshold of concern for the structural class (Step A3 and B3)? 
• are the flavourings or their metabolites endogenous9 (Step A4)?  
• does a NOAEL exist on the flavourings or on structurally related substances (Step A5 and B4)? 
In addition to the data provided for the flavouring substances to be evaluated (candidate substances), 
toxicological background information available for compounds structurally related to the candidate 
substances is considered (supporting substances), in order to assure that these data are consistent with the 
results obtained after application of the Procedure.  
The Procedure is not to be applied to flavourings with existing unresolved problems of toxicity. Therefore, 
the right is reserved to use alternative approaches if data on specific flavourings warranted such actions. 
 
                                                     
 
8 “Innocuous metabolic products”: Products that are known or readily predicted to be harmless to humans at the 
estimated intakes of the flavouring agent” (JECFA, 1997a). 
 
9 “Endogenous substances”: Intermediary metabolites normally present in human tissues and fluids, whether free or 
conjugated; hormones and other substances with biochemical or physiological regulatory functions are not included 
(JECFA, 1997a). 
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Decision tree structural class 
Can the substance be predicted to be metabolised to innocuous products?
Procedure for Safety Evaluation of Chemically Defined Flavouring Substances 
Do the conditions of use result in an intake greater than the 
threshold of concern for the structural class?
Do the conditions of use result in an intake greater than the  
threshold of concern for the structural class? 
Data must be available on the  
substance or closely related  
substances to perform a safety 
evaluation
Does a NOAEL exist for the substance which provides an adequate 
margin of safety under conditions of intended use, or does a NOAEL 
exist for structurally related substances which is high enough to 
accommodate any perceived difference in toxicity between the 
substance and the related substances? 
Does a NOAEL exist for the substance which provides an adequate 
margin of safety under conditions of intended use, or does a NOAEL 
exist for structurally related substances which is  high enough to 
accommodate any perceived difference in toxicity between the 
substance and the related substances? 
  Substance would not be    
expected to be of safety concern
Is the substance or are its metabolites endogenous?
Additional data required 
Step 1. 
Step 2. 
Step A3. 
Step A4. 
Step A5. 
Step B3. 
Step B4.
 Yes No
 Yes 
 No 
No
No
Yes
No
Yes
Yes
Yes
 No
Figure I.1 Procedure for Safety Evaluation of Chemically Defined Flavouring Substances
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ANNEX II: USE LEVELS / MTAMDI 
II.1 Normal and Maximum Use Levels 
For each of the 18 Food categories (Table II.1.1) in which the candidate substances are used, Flavour 
Industry reports a “normal use level” and a “maximum use level” (EC, 2000a). According to the Industry the 
”normal use” is defined as the average of reported usages and ”maximum use” is defined as the 95th 
percentile of reported usages (EFFA, 2002i). The normal and maximum use levels in different food 
categories have been extrapolated from figures derived from 12 model flavouring substances (EFFA, 2004e). 
Table II.1.1 Food categories according to Commission Regulation (EC) No 1565/2000 (EC, 2000a) 
Food category Description 
01.0 Dairy products, excluding products of category 02.0 
02.0 Fats and oils, and fat emulsions (type water-in-oil) 
03.0 Edible ices, including sherbet and sorbet 
04.1 Processed fruit 
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), and nuts & seeds 
05.0 Confectionery 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & legumes, excluding bakery 
07.0 Bakery wares 
08.0 Meat and meat products, including poultry and game 
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  
10.0 Eggs and egg products 
11.0 Sweeteners, including honey 
12.0 Salts, spices, soups, sauces, salads, protein products, etc. 
13.0 Foodstuffs intended for particular nutritional uses 
14.1 Non-alcoholic ("soft") beverages, excl. dairy products 
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts 
15.0 Ready-to-eat savouries 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not be placed in categories 01.0 - 15.0 
 
The “normal and maximum use levels” are provided by Industry for three of the four candidate substances in 
the present flavouring group (Table II.1.2). 
Table II.1.2 Normal and Maximum use levels (mg/kg) for the candidate substances in FGE.46, Revision 1 
(EFFA, 2006g; EFFA, 2007a). 
FL-no Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
16.009 500 
1500 
0 
0 
0 
0 
0 
0 
- 
- 
500 
1500 
0 
0 
0 
0 
500 
1500 
500 
1500 
- 
- 
- 
- 
500 
1500 
0 
0 
0 
0 
500 
1500 
500 
1500 
500 
1500 
16.048 1000 
3000 
0 
0 
0 
0 
0 
0 
- 
- 
1000 
3000 
0 
0 
0 
0 
1000 
3000 
1000 
3000 
- 
- 
- 
- 
1000 
3000 
0 
0 
0 
0 
1000 
3000 
1000 
3000 
1000 
3000 
16.059 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
1 
5 
0,2 
1 
0,4 
2 
- 
- 
0,2 
1 
II.2 mTAMDI Calculations 
The method for calculation of modified Theoretical Added Maximum Daily Intake (mTAMDI) values is 
based on the approach used by SCF up to 1995 (SCF, 1995). The assumption is that a person may consume 
the amount of flavourable foods and beverages listed in Table II.2.1. These consumption estimates are then 
multiplied by the reported use levels in the different food categories and summed up.  
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Table II.2.1 Estimated amount of flavourable foods, beverages, and exceptions assumed to be consumed per 
person per day (SCF, 1995) 
Class of product category Intake estimate (g/day) 
Beverages (non-alcoholic) 324.0 
Foods 133.4 
Exception a: Candy, confectionery 27.0 
Exception b: Condiments, seasonings 20.0 
Exception c: Alcoholic beverages 20.0 
Exception d: Soups, savouries 20.0 
Exception e: Others, e.g. chewing gum e.g. 2.0 (chewing gum) 
 
The mTAMDI calculations are based on the normal use levels reported by Industry. The seven food 
categories used in the SCF TAMDI approach (SCF, 1995) correspond to the 18 food categories as outlined in 
Commission Regulation (EC) No 1565/2000 (EC, 2000a) and reported by the Flavour Industry in the 
following way (see Table II.2.2): 
• Beverages (SCF, 1995) correspond to food category 14.1 (EC, 2000a) 
• Foods (SCF, 1995) correspond to the food categories 1, 2, 3, 4.1, 4.2, 6, 7, 8, 9, 10, 13, and/or 16 
(EC, 2000a) 
• Exception a (SCF, 1995) corresponds to food category 5 and 11 (EC, 2000a) 
• Exception b (SCF, 1995) corresponds to food category 15 (EC, 2000a) 
• Exception c (SCF, 1995) corresponds to food category 14.2 (EC, 2000a) 
• Exception d (SCF, 1995) corresponds to food category 12 (EC, 2000a) 
• Exception e (SCF, 1995) corresponds to others, e.g. chewing gum. 
Table II.2.2 Distribution of the 18 food categories listed in Commission Regulation (EC) No 1565/2000 (EC, 
2000a) into the seven SCF food categories used for TAMDI calculation (SCF, 1995) 
 Food categories according to Commission Regulation 1565/2000 Distribution of the seven SCF food categories 
Key Food category Food Beverages Exceptions 
01.0 Dairy products, excluding products of category 02.0 Food   
02.0 Fats and oils, and fat emulsions (type water-in-oil) Food   
03.0 Edible ices, including sherbet and sorbet Food   
04.1 Processed fruit Food   
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), 
and nuts & seeds 
Food   
05.0 Confectionery   Exception a 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & 
legumes, excluding bakery 
Food   
07.0 Bakery wares Food   
08.0 Meat and meat products, including poultry and game Food   
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  Food   
10.0 Eggs and egg products Food   
11.0 Sweeteners, including honey   Exception a 
12.0 Salts, spices, soups, sauces, salads, protein products, etc.    Exception d 
13.0 Foodstuffs intended for particular nutritional uses Food   
14.1 Non-alcoholic ("soft") beverages, excl. dairy products  Beverages  
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts   Exception c 
15.0 Ready-to-eat savouries   Exception b 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not be Food   
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Table II.2.2 Distribution of the 18 food categories listed in Commission Regulation (EC) No 1565/2000 (EC, 
2000a) into the seven SCF food categories used for TAMDI calculation (SCF, 1995) 
 Food categories according to Commission Regulation 1565/2000 Distribution of the seven SCF food categories 
placed in categories 01.0 - 15.0 
 
The mTAMDI values (see Table II.2.3) are presented for each of the three flavouring substances in the 
present Flavouring Group Evaluation 46, Revision 1, for which Industry has provided use and use levels 
(EFFA, 2006g; EFFA, 2007a). The mTAMDI values are only given for highest reported normal use. 
TableII.2.3 Estimated intakes based on the mTAMDI approach 
FL-no EU Register name mTAMDI 
(μg/person/day) 
Structural class Threshold of concern 
(µg/person/day) 
16.009 Ammonia 110000 Class I 1800 
16.048 Ammonium chloride 220000 Class I 1800 
16.002 Diammonium sulfide  Class III 90 
16.059 Ammonium hydrogen sulphide 220 Class III 90 
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ANNEX III: METABOLISM 
III.1. Absorption, Distribution and Elimination 
The candidate substance ammonia [FL-no: 16.009] is produced endogenously in all mammalian species and 
is a metabolite from the degradation of purines and the deamination of amino acids. In the gut ammonia is 
formed by bacterial degradation of amino acids and nucleic acids from ingested food. The estimated 
production of ammonia in the human intestine may range from 10 mg/day in the duodenum to about 3 g/day 
in the colon. Almost all ammonia formed is absorbed. Ammonia uptake increases with higher pH of luminal 
contents (Castell & Moore, 1971). After absorption ammonia enters the portal circulation, and in healthy 
humans ammonium ions are rapidly transformed to urea in the liver, so only small amounts of ammonium 
reaches the systemic circulation (Summerskill & Wolpert, 1970).  
For ammonium salts the anion may play an important role in determining what effects will occur. 
Ammonium chloride has been used in many animal studies to induce metabolic acidosis, due to the 
formation of hydrogen chloride. Acidosis may occur with other ammonium salts, but the degree of acidosis 
is determined by the ability of the kidneys to excrete the specific anion. Therefore, it is not appropriate to 
extrapolate the findings from one ammonium salt to another (De Sousa et al., 1974). 
Ammonium chloride [FL-no: 16.048] is easily absorbed. Ammonium hydrogen sulphide [FL-no: 16.059] 
will produce ammonia and hydrogen sulphide after absorption. Hydrogen sulphide and soluble sulphides are 
rapidly absorbed following ingestion. Soluble sulphides occur as hydrogen sulphide in body fluids; in terms 
of their systemic effects, no distinctions are recognised between them and hydrogen sulphide (U.S. National 
Research Council, 1979). 
Ammonia is normally present in all tissues. The distribution is pH dependent, as NH3 diffuses more readily 
than NH4+. The lower the pH is in a compartment the higher the amount of ammonia may be (U.S. National 
Research Council, 1979). Although most ingested ammonia that is absorbed in the intestine is transformed to 
urea by the liver, some nitrogen from ammonia has been reported to be incorporated into tissue proteins 
(Vitti et al., 1964; Richards et al., 1968; Fürst et al., 1970). 
The majority of ingested ammonia is excreted as urea in the urine (Haworth et al., 1978; Nelson & Cox, 
2000c). During metabolic acidosis the concentrations of renal glutaminase, which catalyses the release of 
ammonia in the kidney tubular epithelium, increase proportionally to ammonium ion excretion (Davies & 
Yudkin, 1952; Muntwyler et al., 1956; Kamin & Handler, 1957). Ammonia may be excreted through expired 
air, which most likely is due to synthesis of ammonia from salivary urea by oral microflora (Biswas & 
Kleinberg, 1971; Hunt, 1977; Larson et al., 1977; Barrow & Steinhagen, 1980). Mammals may excrete 
ammonia directly into the urine; glutaminase catalyses the release of ammonia in the kidney tubular 
epithelium where it serves as an acceptor of H+ and regulates the acid-base balance (White et al., 1973). Less 
than 1 % of the total amount of ammonia produced in the human intestinal tract is excreted in the faeces 
(Summerskill & Wolpert, 1970). 
In humans (20 male and female volunteers orally administered 9 mg/kg bw ammonium chloride), a transient 
increase in arterial blood ammonia concentrations occurred in about 50 % of the subjects. At 15 minutes 
concentrations peaked (mean of 1.4 mg NH3/l) and by 30 minutes concentrations returned to fasting levels 
(mean of 1.05 mg NH3/l). In subjects with liver cirrhosis (50 males), fasting levels were already elevated 
(mean of 1.56 mg NH3/l) and increased to much higher peak concentrations (mean of 3.7 mg NH3/l) at 15 
minutes than in volunteers without known liver disease. The return to fasting levels was slow and indicated 
impaired hepatic urea synthesis (Conn, 1972). 
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Sulphides are found in a number of foodstuffs and beverages. In cooked foods sulphides may be formed 
from sulphur-containing amino acids. In skimmed milk the level may be 0.8 mg/l. Hydrogen sulphide in 
cooked meat may range from 0.3 mg/kg in beef to 0.4 in lamb. Levels of hydrogen sulphide are higher in 
anaerobically packaged meat (Kraft et al., 1956). 
Hydrogen sulphide is endogenously produced; the main source is from metabolism of sulphur-containing 
amino acids in the intestinal tract. Other sources are bacterial reduction of inorganic sulphate and sulphite in 
the large intestine and fermentation of sulphur-containing amino acids (Richardson et al., 2000). At pH 6 
hydrogen sulphide occurs mainly as the acid, whereas at pH 7.5 a large proportion is in the anionic form, 
mainly as monohydrogen sulphide. At pH 10 sulphide is present in appreciable concentrations (Roediger et 
al., 1997). Six healthy human subjects showed blood sulphide concentrations ranging from 10 to 100 
micromol/l. Whole blood sulphide did not change significantly when increasing amounts of protein from 
meat were fed in the diet; however, faecal sulphide showed a significant increase from 160 to 750 nmol/g in 
four subjects fed diets containing 60 or 420 g meat (Richardson et al., 2000). It has been shown that the 
proximal small intestine extracts sulphate from the circulation against the concentration gradient indicating 
the existence of a sulphur pump (Roediger et al., 1997). 
III.2. Metabolism 
In the liver the majority of excess nitrogen, either in the form of ammonia absorbed from the intestinal tract 
or in the form of glutamine or alanine transported from peripheral tissues, is transformed to urea in the Krebs 
urea cycle. The formation of urea occurs only in the liver.  
Ammonia that is produced in peripheral tissues is not transported as such to the liver but is converted to 
glutamine or alanine. Blood levels of ammonia are kept low, since the compound is toxic and high levels 
may impair brain function. Most tissues convert ammonia to glutamine, using glutamine synthetase. Muscle 
tissue, however, uses the glucose-alanine cycle in which glycolysis produces pyruvate, which produces 
alanine and alpha-ketoglutarate following transamination with glutamate. In the liver alanine loses its 
nitrogen yelding ammonia and pyruvate. Glutamine is hydrolysed in the liver by glutaminase to release 
ammonium for urea synthesis.  
Whatever its source, ammonium that is generated in the liver mitochondria is immediately used together with 
carbon dioxide (as carbonate ion) produced by mitochondrial respiration, to form carbamoyl phosphate, in an 
ATP-dependent reaction. The carbamoyl phosphate, which is an activated carbamoyl group donor, then 
enters the urea cycle. In the cycle, urea is produced from the guanidino group of arginine by the hydrolytic 
enzyme arginase. The other product is ornithine. The amino nitrogen of catabolised amino acids or from 
ammonia is used to convert ornithine back to arginine.  
The cycle has four enzymatic steps:  
1) Carbamoyl phosphate donates its carbamoyl group to orhithine to form citrulline, with the release of 
inorganic phosphor.  
2) The second amino group is introduced from aspartate by a condensation reaction between the amino group 
of aspartate and the carbonyl group of citrulline forming arginosuccinate. Aspartate is generated in 
mitochondria by transamination.  
3) The argininosuccinate is then reversibly cleaved to form free arginine and fumarate.  
4) Arginase then cleaves arginine to yield urea and ornithine. Urea is then released into the cytosolic pool of 
metabolites (Fürst et al., 1969; Pitts, 1971; Haworth et al., 1978; Nelson & Cox, 2000c).  
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Metabolism of hydrogen sulphide may follow three different pathways. The major pathway is oxidation via 
thiosulphate to sulphate and subsequent excretion by the kidney. The primary location for these reactions is 
the liver (Bartholomew et al., 1980). The other options are methylation to methanethiol and dimethyl 
sulphide or reaction with disulphide- or metallo-containing proteins. In the colon, sulphate-reducing bacteria 
reduce sulphate to hydrogen sulphide. Protective mechanisms against injury by hydrogen sulphide may be 
pH regulation and enzymes of detoxification e.g. thiol methyl transferases, which methylate sulphides to 
methyl mercaptans. Thiol methyl transferase activity in man is high in the colon, but does not exceed the 
activity in the liver (Roediger et al., 1997). Although it is shown that methylation is a method of 
detoxification of hydrogen sulphide produced in the intestine, the extent to which the toxicity of exogenous 
hydrogen sulphide is detoxified by methylation is not known. 
The reaction with essential proteins is the reaction that causes the toxicity of hydrogen sulphide after 
inhalation. The mechanism of toxicity of hydrogen sulphide is the inhibition of cytochrome oxidase and, 
through this, the inhibition of the electron transport system (Weisiger et al., 1979; Tabacova, 1986). 
However, hydrogen sulphide may also react with other metalloproteins and this may in some instances 
represent a detoxification pathway (Beauchamp et al., 1984). 
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ANNEX IV: TOXICITY 
Oral acute toxicity data are available for one candidate substance of the present Flavouring Group Evaluation from chemical group 30. 
TABLE IV.1: ACUTE TOXICITY 
Chemical Name [FL-no] Species  Sex  Route  LD50 
(mg/kg bw)  
Reference  Comments 
Ammonium chloride [FL-no: 16.048]  Guinea pig NR Gavage 
0.9 – 1.2 g/kg bw 
NR (Koenig & Koenig, 1949) The dose-range gave rise to pulmonary oedema.  
No study details given.  
Study not considered relevant. 
 Albino rat, guinea pig, 
rabbit 
NR Gavage 
0.05, 0.25, 1.0 
g/kg bw  
NR (Boyd & Seymour, 1946) No untoward effects were noted. No study details given.  
Study not considered relevant. 
 Rat NR Oral 1650 (IUCLID Dataset, 2000d) No study details given. 
NR: Not reported 
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Subacute / subchronic / chronic / carcinogenic toxicity data are available for one candidate substance of the present Flavouring Group Evaluation from 
chemical group 30. 
TABLE IV.2: SUBACUTE / SUBCHRONIC / CHRONIC / CARCINOGENICITY STUDIES 
Chemical Name [FL-no] Species; Sex 
No./Group 
Route Dose levels Duration NOAEL 
(mg/kg bw/day) 
Reference Comments 
Ammonium chloride [FL-no: 
16.048] 
Rabbit (2 kg) 
9 in total 
Gavage in 
drinking 
water 
2 %, 30-50 ml per day (approx. 
300-500 mg/kg bw/day) 
4 weeks - (Joblin & Meeker, 1936) Study was designed to assess the effect 
of abnormal diets on atherosclerosis.  
Study not considered relevant. 
 Not given Oral in diet 3 % (approx. 3 g/kg bw/day) 6 days - (Thompson & Halliburton, 
1966) 
The study assessed mechanisms of renal 
hypertrophy. No details given. Study not 
considered relevant.  
 Mongrel dogs/male 
1 per group 
Tablet 0, 25, 46, 91, 170, 220 mg/kg 
bw/day 
7 days - (Short & Hammond, 1964) The study assessed amount of 
ammonium chloride needed to acidify 
urine without appreciable systemic 
acidosis. Study not considered relevant. 
 Holtzman rats/female Drinking 
water 
0.28 M (approx. 1 g/kg bw/day) 7 days - (Lotspeich, 1965 ) The study assessed mechanisms of renal 
hypertrophy. Study not considered 
relevant. 
 Mongrel dogs/male 
1 control 
5 in dosage group 
Capsule 0 g, 6 g per day 7 days - (Pollak et al., 1965 ) The study aim was to investigate 
enzymatic activity in the kidney in 
metabolic acidosis. No other parameters 
were studied. Study not considered 
relevant. 
 Sprague-Dawley rats 
6 per group 
Drinking 
water 
Gavage 
 
Gavage 
0.28 M 1.2 M; 0.1 ml/10 g bw twice 
daily 
0.6 M; 5 ml twice daily  
7 days - (Janicki, 1970 ) The study assessed mechanisms of renal 
hypertrophy. No other parameters were 
studied. Study not considered relevant. 
 Sprague-Dawley 
rats/male 
Drinking 
water 
0 %, 2 %, 2 % + low-Ca-diet 6 months - (Barzel, 1969) The study assessed the effect of chronic 
ammonium chloride ingestion on bone 
formation. No other parameters were 
studied. 
 Sprague-Dawley 
rats/male 
Drinking 
water 
0 %, 1.5 % (approx 1.5 g/kg bw) 
1.5 % + low-Ca-diet 
330 days - (Barzel & Jowsey, 1969) The study assessed the effect of chronic 
ammonium chloride ingestion on bone 
formation. No other parameters were 
studied.  
 Wistar rats 
10 male, 10 
female/group 
Oral in diet 0 %, 2 %, 4 %  
(2 %= 40.9 mmol/bw/day=2188 
mg/kg bw/day M; 41.9=2242 F;  
4 % = 80.2 mol/bw/ 
day=4291 mg/kg bw/day M 
77.9=4168 F) 
 
4 weeks - (Lina & Kuijpers, 2004 ) The study was designed to assess effects 
of acidogenic diet. Well performed 
study. No NOAEL may be derived. 
 Wistar rat 
10 male, 10 
female/group 
Oral in diet 0 %, 2.1 %, 4 % (2.1 %= 29.8 
mmol/ bw/day=1594 mg/kg bw/day 
M; 33.6=1798 F;  
4 %= 57.0 mmol/ bw/day=3050 
13 weeks - (Lina & Kuijpers, 2004 ) The study was designed to assess effects 
of acidogenic diet. Well performed 
study. 
No NOAEL may be derived.  
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TABLE IV.2: SUBACUTE / SUBCHRONIC / CHRONIC / CARCINOGENICITY STUDIES 
Chemical Name [FL-no] Species; Sex 
No./Group 
Route Dose levels Duration NOAEL 
(mg/kg bw/day) 
Reference Comments 
mg/kg bw/day M 69.1=3697 F), 0 
% + 3 %KCl 
 
 Wistar rat 
15 male, 15 
female/group 
Oral in diet 0 %, 1 %, 2.1 %  
(1 % = 9.0 mmol/bw/day=482 
mg/kg bw/day M, 11.4=610 F;  
2.1 %= 19.0 mmol/ bw/day=1017 
mg/kg bw/day M, 25.6=1370 F), 
0 % + 3 % KCl 
18 months - (Lina & Kuijpers, 2004 ) The study was designed to assess effects 
of acidogenic diet. Well performed 
study. 
No NOAEL may be derived.  
 Wistar rat 
50 male, 50 
female/group 
Oral in diet 0 %, 1 %, 2.1 % (1 %= 8.5 
mmol/bw/ 
day=455 mg/kg bw/day M, 
10.3=551 F; 2.1 %=  18.8 
mmol/bw/day=1006 mg/kg bw/day 
M 22.5=1204 F), 
0 % + 3 % KCl 
30 months - (Lina & Kuijpers, 2004 ) Carcinogenicity study. The study was 
designed to assess effects of acidogenic 
diet. Well performed study. 
No NOAEL may be derived.  
There is no indication that NH4Cl 
induces tumours.  
 
  
 
No developmental and reproductive toxicity data are available for the four candidate substances of the present Flavouring Group Evaluation from chemical 
group 30. 
TABLE IV.3: DEVELOPMENTAL AND REPRODUCTIVE TOXICITY STUDIES 
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In vitro mutagenicity/genotoxicity data are available for two candidate substances of the present Flavouring Group Evaluation from chemical group 30. 
TABLE IV.4: GENOTOXICITY (IN VITRO) 
Chemical Name [FL-no] Test System Test Object Concentration 
 
Result Reference Comments 
Ammonia [16.009] Ames assay S. typhimurium  
TA98; TA100 TA1535, TA1537, TA1538 
and E. Coli WRP uvrA 
500-25000 ppm Negative 
(±S9) 
(Shimizu et al., 1985) Valid study although 
results for ammonia not 
given in paper, reported as 
negative. Ammonium 
fluoride and ammonium 
peroxodisulfate tested in 
same study with negative 
results. 
Ammonium chloride [16.048] Ames assay S. typhimurium  
TA92, TA94, TA98, TA100, TA1535, and 
TA1537 
Up to 10 mg/plate Negative 
(±S9) 
(Ishidate et al., 1984) 
(Ishidate et al., 1988) 
Valid study. 
 Chromosome aberration  Chinese hamster fibroblasts - Positive  
(-S9) 
(Ishidate et al., 1984) 
(Ishidate et al., 1988) 
Valid study. Positive result 
attributed to osmotic 
effects. 
 
 
In vivo mutagenicity/genotoxicity data are available for two candidate substances of the present Flavouring Group Evaluation from chemical group 30.  
TABLE IV.5: GENOTOXICITY (IN VIVO) 
Chemical Name  Test System Test Object  Route Dose Result  Reference  Comments 
Ammonia [16.009] Micronucleus test Mice intraperitoneal 12, 25 or 50 mg/kg  Positive (Yadav & Kaushik, 1997) Study not reliable. 
Ammonium chloride [16.048] Micronucleus test Mice intraperitoneal 31.3-250 mg/kg bw x 4 or single 
doses of 62.5-500 mg/kg bw 
Negative (Hayashi et al., 1988) Valid study. 
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ABBREVIATIONS  
ADI  Acceptable Daily Intake 
ATP  Adenosine TriPhosphate 
BW  Body Weight 
CAS  Chemical Abstract Service 
CEF Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
Chemical Abstract Service 
CHO  Chinese hamster ovary (cells) 
CoE  Council of Europe 
DNA  Deoxyribonucleic acid 
EC European Commission 
EFFA  European Flavour and Fragrance Association 
EFSA  The European Food Safety Authority 
EU  European Union 
FAO  Food and Agriculture Organization of the United Nations  
FEMA  Flavor and Extract Manufacturers Association 
FGE  Flavouring Group Evaluation  
FLAVIS (FL) Flavour Information System (database) 
ID   Identity 
IOFI  International Organization of the Flavour Industry 
JECFA  The Joint FAO/WHO Expert Committee on Food Additives 
LD50  Lethal Dose, 50 %; Median lethal dose 
MS  Mass spectrometry 
MSDI  Maximised Survey-derived Daily Intake 
mTAMDI Modified Theoretical Added Maximum Daily Intake 
No  Number 
NOAEL No Observed Adverse Effect Level 
NOEL  No Observed Effect Level 
SCF  Scientific Committee on Food 
TAMDI Theoretical Added Maximum Daily Intake 
UDS  Unscheduled DNA Synthesis  
WHO  World Health Organisation   
